Physician profile
Corinne Desevo
NPI 1023553468
$899.62
in general payments reported to CMS, 2019-2025
9 companies · $305 in 2025
The $305 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $520 · 2023: $57.13 · 2024: $18.06 · 2025: $305.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $281 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $280.69 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $348.93 | 2022-2025 | Opdualag |
| Janssen Biotech, INC. | $203.25 | 2022-2025 | Rybrevant, Carvykti, Tecvayli |
| Seagen INC. | $125.00 | 2022 | |
| Gilead Sciences, INC. | $113.59 | 2022-2025 | Trodelvy |
| Eisai INC. | $33.61 | 2023-2025 | |
| Novartis Pharmaceuticals Corporation | $29.94 | 2025 | |
| Argenx US, INC. | $17.18 | 2023 | Vyvgart |
| Morphosys, US INC. | $14.72 | 2022 | |
| Amgen INC. | $13.40 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Corinne Desevo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.